Showing results (601-610 of 1,018) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|July 23, 2024
Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause Oncosis in Triple-Negative Breast Cancer Cell Lines by Poisoning the Ion Exchange Membrane Protein TRPM4Makito Mizunuma, Christophe E Redon, Liton Kumar Saha, et al.
Cancer Research Communications|August 5, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology TrialsEsther J Beck, Alexander D Sherry, Marcus A Florez, et al.
Cancer Research Communications|August 5, 2024
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic SignaturesMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Cancer Research Communications|August 1, 2024
Mast Cell Infiltration and Subtype Promote Malignant Transformation of Oral Precancer and Progression of Oral CancerXin-Jia Cai, Chao-Ran Peng, Jian-Yun Zhang, et al.
Cancer Research Communications|August 1, 2024
Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient GlioblastomaCatherine A Behrmann, Kelli N Ennis, Pranjal Sarma, et al.
Cancer Research Communications|July 2, 2024
mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered TumorsConstance A Sobsey, Bjoern C Froehlich, Georgia Mitsa, et al.
Cancer Research Communications|July 2, 2024
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCCYusuke Goto, Keiichi Koshizuka, Toshinori Ando, et al.
Cancer Research Communications|July 23, 2024
Anti-HDGF Antibody Targets EGFR Tyrosine Kinase Inhibitor-Tolerant Cells in NSCLC Patient-Derived XenograftsCindy Q Zhou, Ariel Li, Kaoru Ri, et al.
Cancer Research Communications|July 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway ModulationAnna Rutkowska, H Christian Eberl, Thilo Werner, et al.
Cancer Research Communications|July 19, 2024
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the ElderlyCecilia Sgadari, Biancamaria Scoppio, Orietta Picconi, et al.
Pageof 102